AC
IBB icon

Alexandria Capital’s iShares Biotechnology ETF IBB Stock Holding History

Alexandria Capital’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,209
Closed -$134K – 363
2017
Q3 		$134K Hold
1,209
– – 0.03% 160
2017
Q2 		$125K Sell
1,209
-2,259
-65% -$222K 0.03% 165
2017
Q1 		$339K Buy
3,468
+1,500
+76% +$144K 0.08% 110
2016
Q4 		$174K Hold
1,968
– – 0.04% 139
2016
Q3 		$190K Buy
1,968
+114
+6% +$10.8K 0.04% 144
2016
Q2 		$159K Hold
1,854
– – 0.03% 156
2016
Q1 		$161K Buy
1,854
+1,500
+424% +$134K 0.03% 160
2015
Q4 		$40K Sell
354
-252
-42% -$27.4K 0.01% 280
2015
Q3 		$61K Hold
606
– – 0.01% 207
2015
Q2 		$75K Sell
606
-294
-33% -$35.2K 0.02% 196
2015
Q1 		$103K Sell
900
-900
-50% -$99.3K 0.04% 149
2014
Q4 		$182K Hold
1,800
– – 0.07% 111
2014
Q3 		$164K Hold
1,800
– – 0.07% 117
2014
Q2 		$154K Sell
1,800
-1,800
-50% -$142K 0.07% 120
2014
Q1 		$284K Sell
3,600
-300
-8% -$25K 0.12% 83
2013
Q4 		$295K Sell
3,900
-408
-9% -$28.9K 0.13% 76
2013
Q3 		$301K Hold
4,308
– – 0.14% 78
2013
Q2 		$250K Buy
+4,308
New +$249K 0.12% 88

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
CM
Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Alexandria Capital's IBB Position: Q4 2017 in Review

Alexandria Capital sold out of iShares Biotechnology ETF (IBB) in Q4 2017, closing a stake of 1,209 shares — an estimated $134K sold.

Alexandria Capital first reported a position in IBB in Q2 2013 and held it in 18 quarters. The position peaked at $339K in Q1 2017. 624 funds tracked by Wall St. Rank hold IBB as of Q4 2017.

  • Alexandria Capital reported no remaining iShares Biotechnology ETF position as of Q4 2017 after selling out during the quarter.
  • Alexandria Capital sold 1,209 iShares Biotechnology ETF shares in Q4 2017, an estimated $134K.
  • Alexandria Capital first reported a position in iShares Biotechnology ETF in Q2 2013 and held it in 18 quarters.
  • Alexandria Capital's iShares Biotechnology ETF position peaked at $339K in Q1 2017.
  • 624 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2017.

Based on Alexandria Capital's 13F filing for Q4 2017, filed 9 Feb 2018.